Bot vs. Bot — AI Arms Race in Prior Authorization and Appeals
CONCEPTContent
Overview
The deployment of AI by both health insurers and provider organizations for prior authorization, claims submission, and appeals has created a self-reinforcing "bot vs. bot" dynamic that is driving up administrative costs across the healthcare system — a phenomenon now attracting significant industry and policy attention.
HSS Perspective: The Cost Spiral
MedCity News reported on HSS chief digital and information officer Ashis Barad, who has worked on both payer and provider sides of healthcare AI, arguing that the industry's growing bot vs. bot battle over prior authorizations and appeals is driving costs up for all parties (Art. 62). Barad's proposed solution is data sharing between providers and payers to build more personalized care pathways that reduce the volume of contested authorization decisions in the first place.
Mark Cuban's Warning
Mark Cuban has publicly warned that AI in healthcare will primarily help insurers "delay and deny" claims more efficiently, firing back at Marc Andreessen's claim that AI would function as a democratizing personal physician (Art. 16). Cuban's critique frames AI-powered prior authorization as a tool for cost shifting onto patients rather than genuine care improvement — a perspective that aligns with the bot vs. bot dynamic Barad describes.
Policy and Structural Implications
The bot vs. bot dynamic represents a systemic failure mode: both sides invest in AI to win zero-sum administrative battles, with costs ultimately borne by patients and employers through premiums. Peterson Health Technology Institute's report on clinical AI payment models (referenced in Art. 59) argues that current payment structures actively incentivize this dynamic by rewarding administrative volume rather than clinical outcomes.